Top compounds associated with response to AURKAIP1


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC -0.049 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.1
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.05 0.1
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC -0.07 0.1
mRNA Erlotinib CCLE pan-cancer AAC -0.066 0.1
mRNA ruxolitinib GDSC1000 pan-cancer AAC -0.047 0.1
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.05 0.1
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.053 0.1
mRNA PF-543 CTRPv2 pan-cancer AAC -0.055 0.1
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.062 0.1
Download CSV